Evaluation of first trimester maternal serum inhibin-A for preeclampsia screening.

Sakita MoungmaithongAngel H KwanAda W TseNatalie K WongMichelle S LamJing WangLiona Chiu Yee PoonDaljit S Sahota

Published in: PloS one (2023)

Replacing PlGF by inhibin-A or adding inhibin-A as an additional biomarker in and to the FMF triple screening test for preterm PE does not improve screening performance and will fail to identify pregnancies that are currently identified by the FMF triple test.

Keyphrases

pregnancy outcomes
preterm birth
gestational age
early onset
birth weight
low birth weight
body mass index